EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomaterial Platforms for Spatiotemporal Control of mRNA Delivery in Tissue Engineering and Regenerative Medicine: Design Rules, Therapeutic Applications, and Translational Roadmap

Huachun Pan iD, Shumin Yang iD, Katarina Holubova, Huifang Yin, Hongbo Chen iD, Xintian Zheng iD, Xiangan Han iD, Jinqiu Zhang, Xueping Li iD, Hui Zhang iD, Xiaojun Cai iD, Václav Slovák iD und 3 weitere

Small · 05.11.2026

DOI: 10.1002/smll.76600 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 05.11.2026. Verfasst von Huachun Pan und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Longyan University, Longyan, People's Republic of China. Die Arbeit nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MINIATURA 10 funding scheme, European Union under the LERCO project, Fujian Provincial Natural Science Foundation General Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) enables transient, non‐integrating, and programmable protein expression, yet its regenerative potential is constrained by extracellular instability, inefficient cytosolic delivery, rapid tissue clearance, innate immune activation, and poor alignment between expression kinetics and healing programs. Biomaterial platforms address these barriers by integrating molecular protection and intracellular delivery with local retention, controlled release, biophysical support, and microenvironmental regulation. This Review critically examines nanoscale carriers, macroscale depots and scaffolds, and hierarchical nano‐in‐matrix and stimulus‐responsive systems for spatiotemporally controlled mRNA delivery. We propose a cargo–target–timing framework linking mRNA chemistry and material properties to delivery, expression, immune responses, and tissue repair. Evidence across musculoskeletal, cardiovascular, neural, cutaneous, and visceral tissues is assessed to identify candidate expression profiles, their biological rationale, and the comparative studies needed to define therapeutic windows. Critical quality attributes, longitudinal monitoring, cross‐study comparability, manufacturing, storage, dosing, safety, clinically relevant models, and regulatory positioning are evaluated. Finally, a stage‐gated translational roadmap and artificial intelligence (AI)‐enabled, adaptive, and personalized design strategies are presented. By integrating structure–property relationships with tissue‐specific therapeutic windows and product‐development requirements, this Review establishes actionable principles for advancing mRNA‐biomaterial systems toward regenerative products.

Schlagwörter

Stichwörter der Autor:innen

biomaterial scaffoldscontrolled releaselocalized deliverymRNA therapeuticsnanocarrierstissue regeneration

Autor:innen und Institutionen

  • College of Life Sciences, Longyan University, Longyan, People's Republic of China.
  • Department of Chemistry, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
  • Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China.
  • College of Life Sciences, Nanjing Agricultural University, Nanjing, People's Republic of China.
  • School of Life Sciences, Tianjin University, Tianjin, People's Republic of China.
  • College of Veterinary Medicine, South China Agricultural University, Guangzhou, People's Republic of China.

ORCID-Profile: Huachun Pan, Shumin Yang, Hongbo Chen, Xintian Zheng, Xiangan Han, Xueping Li, Hui Zhang, Xiaojun Cai, Václav Slovák, Lihong Zhang, Quazi T H Shubhra

Förderung

  • MINIATURA 10 funding scheme
  • European Union under the LERCO project
  • Fujian Provincial Natural Science Foundation General Project
  • Doctoral Start-up Project
  • China-Laos Project: Fujian Provincial Foreign Cooperation Project

Zitieren

APA

Pan, H., Yang, S., Holubova, K., Yin, H., Chen, H., Zheng, X., Han, X., Zhang, J., Li, X., Zhang, H., Cai, X., Slovák, V., Zhang, L., Mo, Q., & Shubhra, Q. T. H. (2026). Biomaterial Platforms for Spatiotemporal Control of mRNA Delivery in Tissue Engineering and Regenerative Medicine: Design Rules, Therapeutic Applications, and Translational Roadmap. Small. https://doi.org/10.1002/smll.76600

Vancouver

Pan H, Yang S, Holubova K, Yin H, Chen H, Zheng X, et al. Biomaterial Platforms for Spatiotemporal Control of mRNA Delivery in Tissue Engineering and Regenerative Medicine: Design Rules, Therapeutic Applications, and Translational Roadmap. Small. 2026. doi:10.1002/smll.76600

BibTeX
@article{Pan2026,
  author = {Pan, Huachun and Yang, Shumin and Holubova, Katarina and Yin, Huifang and Chen, Hongbo and Zheng, Xintian and Han, Xiangan and Zhang, Jinqiu and Li, Xueping and Zhang, Hui and Cai, Xiaojun and Slovák, Václav and Zhang, Lihong and Mo, Quan and Shubhra, Quazi T H},
  title = {Biomaterial Platforms for Spatiotemporal Control of mRNA Delivery in Tissue Engineering and Regenerative Medicine: Design Rules, Therapeutic Applications, and Translational Roadmap},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.76600}
}
Kostenlos starten →